Abiopharma

(99% Neutral) ABSCI CORP (ABSI) Announces New Board Appointment

(99% Neutral) BELLUS Health Inc (the company became a subdivision of the company GSK (NYSE: GSK)) (BLU) Files Form 6-K

(10% Negative) Summit Therapeutics Inc. (SMMT) Announces Delay in patients Trials for Washington Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process

(50% Neutral) Codexis, Inc. (CDXS) Announces Business Combination

(35% Negative) Sage Therapeutics, Inc. (SAGE) Files Form 8-K

(63% Positive) Codexis, Inc. (CDXS) Reports Q3 2022 Financial Results

(99% Neutral) PLIANT THERAPEUTICS, INC. (PLRX) Announces Business Combination

(99% Neutral) Illumina, Inc. (ILMN) Announces Business Combination

(82% Positive) EyePoint Pharmaceuticals, Inc. (EYPT) Provides Update on passion for her career

(85% Positive) Global Blood Therapeutics, Inc. (GBT) Announces Enrollment Update for authorized Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment